{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:41:24Z","timestamp":1778834484587,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.7759\/cureus.107015","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:07:21Z","timestamp":1776164841000},"source":"Crossref","is-referenced-by-count":1,"title":["Endovascular Salvage of Native Arteriovenous Fistulas: Post-Intervention Primary and Cumulative Patency Outcomes in a Colombian Regional Referral Center"],"prefix":"10.7759","author":[{"given":"Oscar F","family":"Vargas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Salcedo-Mesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan R","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Gemav. C\u00f3digo f\u00edstula documento de consenso. (2022). Accessed: April 14, 2026: https:\/\/gemav.org\/wp-content\/uploads\/2025\/05\/codigo_fistula.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2017.11.004","article-title":"Spanish clinical guidelines on vascular access for haemodialysis","volume":"37 Suppl 1","author":"Ibeas J","year":"2017","unstructured":"Ibeas J, Roca-Tey R, Vallesp\u00edn J, et al.. Spanish clinical guidelines on vascular access for haemodialysis. Nefrologia. 2017, 37 Suppl 1:1-191. 10.1016\/j.nefro.2017.11.004","journal-title":"Nefrologia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.circv.2024.04.007","article-title":"Accesos vasculares para di\u00e1lisis","volume":"31","author":"Ju\u00e1rez Crespo C","year":"2024","unstructured":"Ju\u00e1rez Crespo C, Tasc\u00f3n Quevedo V, Garc\u00eda Mart\u00ednez B, et al.. Accesos vasculares para di\u00e1lisis. Cir Cardiovasc. 2024, 31:175-82. 10.1016\/j.circv.2024.04.007","journal-title":"Cir Cardiovasc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2021.4527","article-title":"Arteriovenous fistula maturation, functional patency, and intervention rates","volume":"156","author":"Huber TS","year":"2021","unstructured":"Huber TS, Berceli SA, Scali ST, et al.. Arteriovenous fistula maturation, functional patency, and intervention rates. JAMA Surg. 2021, 156:1111-8. 10.1001\/jamasurg.2021.4527","journal-title":"JAMA Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2016.07.015","article-title":"Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit","volume":"27","author":"Dariushnia SR","year":"2016","unstructured":"Dariushnia SR, Walker TG, Silberzweig JE, et al.. Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit. J Vasc Interv Radiol. 2016, 27:1518-30. 10.1016\/j.jvir.2016.07.015","journal-title":"J Vasc Interv Radiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2023.08.016","article-title":"ACR appropriateness criteria\u00ae dialysis fistula malfunction","volume":"20","author":"Higgins MC","year":"2023","unstructured":"Higgins MC, Diamond M, Mauro DM, et al.. ACR appropriateness criteria\u00ae dialysis fistula malfunction. J Am Coll Radiol. 2023, 20:S382-412. 10.1016\/j.jacr.2023.08.016","journal-title":"J Am Coll Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.0535","article-title":"Arteriovenous access for hemodialysis: a review","volume":"331","author":"Lok CE","year":"2024","unstructured":"Lok CE, Huber TS, Orchanian-Cheff A, Rajan DK. Arteriovenous access for hemodialysis: a review. JAMA. 2024, 331:1307-17. 10.1001\/jama.2024.0535","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124382","article-title":"Effectiveness of endovascular treatment in native hemodialysis fistula dysfunction: long-term outcomes","volume":"14","author":"Beyazal M","year":"2025","unstructured":"Beyazal M, Kaba E. Effectiveness of endovascular treatment in native hemodialysis fistula dysfunction: long-term outcomes. J Clin Med. 2025, 14:10.3390\/jcm14124382","journal-title":"J Clin Med"},{"key":"ref9","unstructured":"National Kidney Foundation. NKF KDOQI clinical practice guidelines. (2020). Accessed: April 14, 2026: https:\/\/www.kidney.org\/professionals\/kdoqi."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238788","article-title":"Percutaneous intervention for salvage of non-maturing arteriovenous fistulas: Which is the better approach, arterial or venous?","volume":"15","author":"Lee SM","year":"2020","unstructured":"Lee SM, Na JB, Choi HC, et al.. Percutaneous intervention for salvage of non-maturing arteriovenous fistulas: Which is the better approach, arterial or venous?. PLoS One. 2020, 15:e0238788. 10.1371\/journal.pone.0238788","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/15266028221075230","article-title":"Long-term results of interwoven nitinol stents to treat the radiocephalic anastomotic arteriovenous fistula stenosis","volume":"30","author":"Thomas SD","year":"2023","unstructured":"Thomas SD, Peden S, Katib N, et al.. Long-term results of interwoven nitinol stents to treat the radiocephalic anastomotic arteriovenous fistula stenosis. J Endovasc Ther. 2023, 30:176-84. 10.1177\/15266028221075230","journal-title":"J Endovasc Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13321216","article-title":"Clinical trial end points for hemodialysis vascular access: background, rationale, and definitions","volume":"13","author":"Shenoy S","year":"2018","unstructured":"Shenoy S, Allon M, Beathard G, et al.. Clinical trial end points for hemodialysis vascular access: background, rationale, and definitions. Clin J Am Soc Nephrol. 2018, 13:490-4. 10.2215\/CJN.13321216","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.01.006","article-title":"Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial","volume":"107","author":"Razavi MK","year":"2025","unstructured":"Razavi MK, Balamuthusamy S, Makris AN, et al.. Six-month safety and efficacy outcomes from the randomized-controlled arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial. Kidney Int. 2025, 107:740-50. 10.1016\/j.kint.2025.01.006","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/AS9.0000000000000199","article-title":"Radiocephalic arteriovenous fistula patency and use: a post hoc analysis of multicenter randomized clinical trials","volume":"3","author":"Heindel P","year":"2022","unstructured":"Heindel P, Yu P, Feliz JD, et al.. Radiocephalic arteriovenous fistula patency and use: a post hoc analysis of multicenter randomized clinical trials. Ann Surg Open. 2022, 3:e199. 10.1097\/AS9.0000000000000199","journal-title":"Ann Surg Open"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2025.05.021","article-title":"Longitudinal outcomes of forearm versus upper arm arteriovenous fistulas","volume":"82","author":"Manchella MK","year":"2025","unstructured":"Manchella MK, Appah-Sampong A, Ruan M, et al.. Longitudinal outcomes of forearm versus upper arm arteriovenous fistulas. J Vasc Surg. 2025, 82:1048-1057.e1. 10.1016\/j.jvs.2025.05.021","journal-title":"J Vasc Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2022.04.510","article-title":"Patency and complications of arterio-venous fistula created in pre- and post-dialysis settings","volume":"32","author":"Azeem SM","year":"2022","unstructured":"Azeem SM, Ehsan O, Khan MI. Patency and complications of arterio-venous fistula created in pre- and post-dialysis settings. J Coll Physicians Surg Pak. 2022, 32:510-3. 10.29271\/jcpsp.2022.04.510","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.13258","article-title":"Impact of the causes of arteriovenous fistula stenosis on the patency rate of arteriovenous fistula following percutaneous transluminal angioplasty","volume":"38","author":"Xia M","year":"2025","unstructured":"Xia M, He QE, Zhou WJ, et al.. Impact of the causes of arteriovenous fistula stenosis on the patency rate of arteriovenous fistula following percutaneous transluminal angioplasty. Semin Dial. 2025, 38:201-6. 10.1111\/sdi.13258","journal-title":"Semin Dial"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48691-4","article-title":"Risk factors for arteriovenous fistula dysfunction in hemodialysis patients: a retrospective study","volume":"13","author":"Zhang F","year":"2023","unstructured":"Zhang F, Li J, Yu J, et al.. Risk factors for arteriovenous fistula dysfunction in hemodialysis patients: a retrospective study. Sci Rep. 2023, 13:21325. 10.1038\/s41598-023-48691-4","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2024.10.006","article-title":"Outcomes following arteriovenous fistula creation in medicare beneficiaries with end-stage kidney disease","volume":"234","author":"Kong NW","year":"2025","unstructured":"Kong NW, Kim JM, Krawisz AK, et al.. Outcomes following arteriovenous fistula creation in medicare beneficiaries with end-stage kidney disease. Am J Cardiol. 2025, 234:79-86. 10.1016\/j.amjcard.2024.10.006","journal-title":"Am J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.07.056","article-title":"Outcomes of endovascular salvage of clotted arteriovenous access and predictors of patency after thrombectomy","volume":"71","author":"Tan RY","year":"2020","unstructured":"Tan RY, Pang SC, Teh SP, et al.. Outcomes of endovascular salvage of clotted arteriovenous access and predictors of patency after thrombectomy. J Vasc Surg. 2020, 71:1333-9. 10.1016\/j.jvs.2019.07.056","journal-title":"J Vasc Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2021.11.026","article-title":"Autogenous vascular access in American Indians","volume":"83","author":"Kempe K","year":"2022","unstructured":"Kempe K, Nelson PR, Mushtaq N, et al.. Autogenous vascular access in American Indians. Ann Vasc Surg. 2022, 83:108-16. 10.1016\/j.avsg.2021.11.026","journal-title":"Ann Vasc Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.25259\/ijn_539_23","article-title":"Outcomes of endovascular treatment for salvaging failed hemodialysis arteriovenous fistula - role of balloon angioplasty as initial therapy","volume":"34","author":"Vignesh S","year":"2024","unstructured":"Vignesh S, Mukuntharajan T, Sampathkumar K. Outcomes of endovascular treatment for salvaging failed hemodialysis arteriovenous fistula - role of balloon angioplasty as initial therapy. Indian J Nephrol. 2024, 34:583-8. 10.25259\/ijn_539_23","journal-title":"Indian J Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5812\/iranjradiol.11386","article-title":"Endovascular stent placement of juxtaanastomotic stenosis in native arteriovenous fistula after unsuccessful balloon angioplasty","volume":"10","author":"Ozkan B","year":"2013","unstructured":"Ozkan B, G\u00fcng\u00f6r D, Y\u0131ld\u0131r\u0131m UM, et al.. Endovascular stent placement of juxtaanastomotic stenosis in native arteriovenous fistula after unsuccessful balloon angioplasty. Iran J Radiol. 2013, 10:133-9. 10.5812\/iranjradiol.11386","journal-title":"Iran J Radiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI clinical practice guideline for vascular access: 2019 update","volume":"75","author":"Lok CE","year":"2020","unstructured":"Lok CE, Huber TS, Lee T, et al.. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020, 75:S1-S164. 10.1053\/j.ajkd.2019.12.001","journal-title":"Am J Kidney Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2024.11.006","article-title":"Single or dual antiplatelet therapy improves one-year arteriovenous graft patency and overall survival","volume":"111","author":"Ebertz DP","year":"2025","unstructured":"Ebertz DP, Bose S, De Valle A, et al.. Single or dual antiplatelet therapy improves one-year arteriovenous graft patency and overall survival. Ann Vasc Surg. 2025, 111:367-85. 10.1016\/j.avsg.2024.11.006","journal-title":"Ann Vasc Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/11297298251332043","article-title":"Approaches to improve 12-month circuit primary patency and target lesion primary patency in arteriovenous fistulae: An umbrella review of systematic reviews and meta-analyses","volume":"27","author":"Ravindhran B","year":"2026","unstructured":"Ravindhran B, Parovic M, Staniland T, et al.. Approaches to improve 12-month circuit primary patency and target lesion primary patency in arteriovenous fistulae: An umbrella review of systematic reviews and meta-analyses. J Vasc Access. 2026, 27:63-71. 10.1177\/11297298251332043","journal-title":"J Vasc Access"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2020.11.006","article-title":"La mortalidad de los pacientes en hemodi\u00e1lisis est\u00e1 asociada con su situaci\u00f3n cl\u00ednica al comienzo del tratamiento","volume":"461","author":"Arriba G","year":"2021","unstructured":"Arriba G, Guti\u00e9rrez Avila G, Torres Guinea M, et al.. La mortalidad de los pacientes en hemodi\u00e1lisis est\u00e1 asociada con su situaci\u00f3n cl\u00ednica al comienzo del tratamiento. 2021, 461:6. 10.1016\/j.nefro.2020.11.006"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Mark PB","year":"2025","unstructured":"Mark PB, Stafford LK, Grams ME, et al.. Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet. 2025, 406:2461 - 2482. 10.1016\/S0140-6736(25)01853-7","journal-title":"The Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/478971-endovascular-salvage-of-native-arteriovenous-fistulas-post-intervention-primary-and-cumulative-patency-outcomes-in-a-colombian-regional-referral-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:07:23Z","timestamp":1776164843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/478971-endovascular-salvage-of-native-arteriovenous-fistulas-post-intervention-primary-and-cumulative-patency-outcomes-in-a-colombian-regional-referral-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.107015","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}